India sends 300,000 Measles and Rubella vaccine doses to Bolivia amid outbreak
"India dispatched a consignment of 300,000 doses of Measles & Rubella vaccines along with ancillary supplies to support Bolivia in managing the outbreak of the disease. India stands by its friends in the Global South," Ministry of External Affairs spokesperson Randhir Jaiswal said in a post on X.
The shipment arrives at a crucial time as Bolivia has declared a National Health Emergency due to a resurgence of measles cases in several areas. So far, 60 confirmed cases have been reported, according to Xinhua.
"After urgently convening the National Strategic Council for Health Emergencies, in response to the measles epidemic that the country is experiencing and the high risk of the disease spreading, we have decided to declare a National Health Emergency with the firm intention of protecting the health and lives of the Bolivian people," Bolivian President Luis Arce Catacora announced on social media, as quoted by Xinhua.
The emergency move aims to stop the virus from spreading through mass vaccination efforts and a coordinated response involving local governments, regional bodies, and international organisations.
According to Catacora, this step will improve the country's response capacity, activate emergency protocols, and ensure that vaccines are available, especially for children under five. He urged the public to cooperate with health authorities and ensure full immunisation.
"Our duty is clear: to protect our children and the entire population from a threat that has already raised health alerts across the continent," he said.
Bolivia's Health Minister Maria Renee Castro also expressed concern, stressing the severity of the situation and the risks faced by vulnerable groups.
"It is essential that parents get their children vaccinated. The country has 500,000 doses, specifically for girls and boys," Castro said, according to Xinhua.
She added that measles is a highly contagious viral illness that can cause serious complications, including pneumonia, encephalitis, or even death, particularly among children with malnutrition or weak immune systems.
According to Xinhua, the recent rise in measles cases in Bolivia has been linked to falling vaccination rates, disruptions in healthcare during the COVID-19 pandemic, misinformation, and lack of continuity in prevention programmes.
Prime Minister Narendra Modi met Bolivian President Luis Arce Catacora on the sidelines of the BRICS Summit in Rio de Janeiro, where the two leaders reviewed the progress of bilateral cooperation and explored new areas of partnership, especially in the field of critical minerals.
According to the Ministry of External Affairs, "The two leaders reviewed bilateral cooperation and expressed satisfaction with the progress achieved." They also discussed collaboration in trade and commerce, Digital Public Infrastructure and UPI, health and pharmaceuticals, traditional medicine, small and medium industries, training, and capacity building.
"Both leaders recognized the potential for enhanced collaboration in the critical minerals sector and developing sustainable and mutually beneficial partnerships in the field," the statement said.
The MEA noted that both sides "expressed satisfaction over the ongoing development cooperation between the two countries, including through Quick Impact Projects and capacity-building initiatives under the ITEC scholarship programmes."
Prime Minister Modi also conveyed India's support for the people of Bolivia following the deadly floods that affected La Paz and other regions earlier this year. "Prime Minister expressed solidarity with the people of Bolivia in the wake of the severe flooding that occurred in March-April 2025 in Laz Paz and several other parts of the country," the MEA said.
He further congratulated Bolivia on joining the International Solar Alliance and extended greetings on the upcoming national milestone. "Prime Minister conveyed his warm greetings to the people and Government of Bolivia on the occasion of the country's bicentennial celebration, marking 200 years of independence on 6th August 2025," the statement added. (ANI)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
Don't ignore these heart warning signs in your 40s, 50s, and 60s
Heart warning signs Heart attacks are no longer just a concern for seniors. New research reveals that heart disease is hitting younger adults, especially women, harder than ever. With a 66% rise in heart attacks among adults aged 18 to 44, it's critical to recognise early warning signs of heart trouble. Experts say lifestyle habits, rising obesity, and even past COVID infections are driving this surge. If you're in your 40s, 50s, or 60s, now is the time to take charge of your heart health and prevent a silent crisis. Here's what you need to know and how to protect yourself. Heart disease is often considered a concern for older adults, but new findings show a troubling trend: heart attacks are on the rise among younger adults, particularly women. In an interview with Yahoo! Life , Dr. C. Noel Bairey Merz, director of the Barbra Streisand Women's Heart Center at Cedars-Sinai's Smidt Heart Institute, shared her insights into this alarming development. She pointed out that while heart attacks among adults aged 18 to 44 are still relatively rare, their incidence has jumped by over 66% since 2019. Meanwhile, heart attack rates have decreased in other adult age groups. According to Apollo Hospitals, it is true that increasing age is a risk factor, and heart attacks are more common after 45 in men and after 55 in women, with risk increasing as one grows older. A heart attack is far from rare in the younger age group of 30 to 40 years. Coronary Artery Disease (CAD) occurs at a younger age in Indians, with over 50% of CAD mortality occurring in individuals aged less than 50 years. Prevalence of acute MI (heart attack) as high as 25 to 40% has been reported in the young, that is, patients below 40 years of age. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Cardiologists Confirm: 60-Year-Old Sheds Fat With 4 Ingredients The Healthy Way Learn More Undo Warning signs behind the sudden rise in heart attacks Obesity is rising, and it's hitting young adults hard. Obesity is a growing issue in all age groups, but younger adults seem to be feeling the effects on their heart health more than older generations. Dr. Andrew Moran , a preventive cardiologist and epidemiologist at Columbia University, told Yahoo Life that the rise in obesity is happening faster in people under 50 than in older adults. One reason may be that eating habits often form early in life. Dr. C. Noel Bairey Merz, a cardiologist at Cedars-Sinai, explained to Yahoo Life that she still eats the way she did growing up, before the fast food boom. In contrast, today's younger adults were raised on fast food, sugary drinks, and processed snacks like Doritos and snack bars. Many continue those habits into adulthood. These poor diets, combined with more sedentary lifestyles, have contributed to what Bairey Merz calls the 'diabesity' epidemic—a dangerous combination of obesity and diabetes. Both of these conditions raise the risk of high blood pressure, heart disease, and heart attacks because they damage blood vessels and put extra strain on the heart. COVID-19 may have worsened heart health COVID-19 doesn't just affect the lungs; it can also harm the heart. The virus can cause heart inflammation (myocarditis) and other cardiovascular issues, even in younger people. Dr. Moran noted to Yahoo Life that many young adults who had serious cases of COVID also had other risk factors like obesity. One study found a 30% rise in heart attack deaths among people ages 25 to 44 during the first two years of the pandemic. Even after recovering from COVID, around 4 out of every 100 people in the U.S. experience heart-related symptoms within a year. Dr. Ashish Sarraju from the Cleveland Clinic added that while traditional risks like obesity and high blood pressure matter, the impact of COVID on heart health is something doctors are still studying closely. Young men often don't get heart screenings Men are generally more likely than women to have heart attacks. But younger men may be even more at risk because many don't regularly visit the doctor. Dr. Moran explained that young women are more likely to see a doctor each year for gynaecological checkups, but young men often miss these routine visits. As a result, many men don't realise they have high blood pressure or diabetes until they end up in the hospital. Unique heart risks facing younger women Heart attack rates are increasing fastest among women ages 35 to 54. Between 1995 and 2014, hospitalisations for heart attacks in this group jumped from 21% to 31%, according to one study. Dr. Bairey Merz told Yahoo Life she's trying to understand why, and several factors may be playing a role: Diabesity : Diabetes is a stronger risk factor for heart disease in women than in men, though it's not clear why. Smoking and vaping : Many young women start smoking or vaping in college, often to manage their weight. Bairey Merz warns that e-cigarettes and cannabis are just as harmful to the heart as regular cigarettes. Stress and hormonal changes : High stress levels—often made worse by social media—can disrupt menstrual cycles. Missing periods can lower estrogen levels, which may increase heart disease risk. What you can do to protect your heart Though the warnings are constant, you can do some damage control and restore the health of your heart, or in other words, you can take steps now to reduce your risk of heart disease and heart attacks. Here's what professionals suggest: Eat more fresh foods : Dr. Moran recommends eating more fruits and vegetables and cutting back on packaged and processed foods. This helps lower your sodium intake, which is important for your heart health. Be physically active: Try to stay active most days of the week, even if it's just a walk. Consuming healthy food and doing physical exercise help you to maintain a healthy weight and reduce the chances of developing high blood pressure. Don't smoke or vape: Avoid all tobacco and cannabis products; they can all harm your heart. Manage stress: Pay attention to your mental health, especially if you feel overwhelmed or anxious. Also read | Bowel cancer warning for young adults: Red meat and sugar may be to blame
Time of India
7 hours ago
- Time of India
From ouch to opportunity: India chases instant relief as pain market swells to Rs 16,000 crore; 5 brands pop up every week
India's pain relieving market is soaring, as more and more people are rushing to use over-the-counter (OTC) pills, sprays and creams to soothe everyday aches and pains. According to Nielsen data cited by industry executives, in the past five years, the segment has grown by more than a billion dollars, becoming the largest category within the non-prescription space. Since the onset of the pandemic, around five new pain relief brands have been launched each week on average, as per an ET report. In 2020, there were 1,552 brands catering to pain relief, including household names such as Volini, Omnigel, Dolo and Saridon. That figure has now soared to 2,771. Consumers are prioritising quick relief, said Shivam Puri, managing director at Cipla Health, 'Rise of urbanisation and increase in chronic illnesses have led to the need for faster, more convenient formats that are accessible across platforms,' Puri told ET. This rising demand comes despite continued warnings from healthcare professionals about the risks of indiscriminate painkiller use. Explosive growth The pain relief segment, particularly in urban markets, is largely driven by lifestyle factors such as gym injuries and sports-related strains. As a result, the combined market for analgesics and rubefacients has more than doubled, from Rs 6,820 crore in May 2020 to Rs 15,905 crore in May 2025, representing a compound annual growth rate (CAGR) of 18%. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Many Are Watching Tariffs - Few Are Watching What Nvidia Just Launched Seeking Alpha Read More Undo This is three times faster than the broader OTC market, which has grown at 6% CAGR to reach Rs 80,000 crore. Analgesics account for 75% of the pain management medication category. Paracetamol remains the dominant contributor, as per data from PharmaTrac, cited by ET. Sandeep Verma, who heads Bayer Pharmaceuticals' consumer health business for South Asia, noted a shift in perception since the Covid-19 outbreak. 'A lot of Indians view taking pain relief medication as a sign of weakness or worry about becoming dependent on it. Covid made many of us more aware of how stress, exhaustion, and even mild but recurring pain can chip away at our wellbeing and productivity,' he was quotde as saying. From chronic pain to lifestyle ailments Experts say that pain medications are being increasingly used to treat a wider range of issues, including inflammation and adjacent issues, leading to growing demand for pills. 'The analgesic segment that is dominated by paracetamols has been growing at a steady rate of 10%. This is because paracetamol medications are taken alongside other conditions that could include arthritis, any other bacterial or viral infection,' Sheetal Sapale, vice president, commercial, at PharmaTrac was quoted as saying. Nitin Kumar Sinha, consultant physician at WeCare Wellness in Mumbai, attributed the trend to rising lifestyle-related ailments. 'Lack of physical exercise, increase in body weight leading to knee and joint pain, anxiety, depression are all causes of increase in body pain, headaches or migraine,' he told ET. He also warned that self-medication is on the rise which can have serious consequences if used over a prolonged period of time, such as damage to the kidneys. IPCA's Zerodol SP, Janssen's Ultracet, GSK's Calpol, Micro Lab's Dolo, Torrent's Chymoral Forte and Cipla's Ibugesic Plus, are one of the top selling drugs. Most of these are prescription medications. Skin creams, allergies also see rise in OTC demand Pain relief isn't the only area where Indians are increasingly self-medicating. The demand for dermatological creams, traditionally prescribed by dermatologists, is also surging, particularly among Gen Z consumers. Bhanu Prakash, partner and healthcare services industry leader at Grant Thornton, said, 'Over-the-counter as a segment has grown post-Covid because of more knowledge and information for categories including anti-allergic medications, skin creams, tear drops among others.' Derma products, which are used to treat issues related to the skin and scalp, are now the second-largest non-prescription category after pain, expanding at a CAGR of 8% over the last five years, to become a Rs 14,854 crore market. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
The Print
8 hours ago
- The Print
AI can help build a healthier world. Here is how
As the world was still reeling from COVID-19, an outbreak of Mpox struck the globe from 2022 to 2023. The outbreaks were first seen in remote mining communities and last-mile villages in the Democratic Republic of Congo (DRC) and then spread to neighbouring countries. This resulted in a historically rare disease spreading widely outside its endemic regions to Europe and Asia. Mpox is highly virulent and can be fatal. The regions where the disease is endemic see overlapping challenges of conflict, changing weather patterns and population displacement, intersecting with limited infrastructure and health personnel. In DRC and neighbouring regions that see continued outbreaks, rapid testing for Mpox within communities and at borders was and still is critical to maintain global health security. How AI helps stem the spread of Mpox This is where a new ally joined this fight: artificial intelligence (AI). In Rwanda, we collaborated with the government to develop and deploy an Mpox skin image detection AI tool, enabling health workers to use mobile devices at key border entry points with Uganda, Burundi and the DRC. The AI skin test complements molecular screening methods to drive early detection, outbreak control and protection of vulnerable groups at risk of serious Mpox cases. Show Full Article Teaching an algorithm to screen and support surveillance is transferable to other infectious diseases, tailored to contexts and populations. Global Fund-financed countries have deployed AI since 2018 through health ministries and communities to expand healthcare access, increase testing volumes and guide health workers to where their work is most needed to manage tuberculosis. This existing base can be expanded, at a reasonable cost, to screen for other infectious diseases too. For this next era of AI innovation, the Global Fund and other multilaterals must balance the push to deploy cost-effective AI tools across the health sector, while maintaining investment in good, secure digital foundations. Health systems operate across the care continuum from diagnosis to supporting triage and treatment to decision-support, even in countries where there is finite human and infrastructural capacity. As artificial intelligence reshapes every industry, the Global Fund works with countries to ask critical questions relevant to the health sector: What are the challenges we are facing? Which AI applications make sense today? How can they be deployed to accelerate progress? How can they be scaled? The answers lie in a clear theory of change. By adopting new technologies, countries have successfully aligned innovations to their digital maturity and financial readiness, advancing in step with their capacity, rather than waiting for the 'perfect' foundations or leaping too far ahead. Pilots need to be embedded in national health platforms AI tools must be designed for scale, meaning moving beyond single-use apps towards modular, open-architecture platforms. From the start, pilots should be embedded within health ministries or national digital-health platforms and built with interoperable components that can be adapted for new diseases, geographies, or functions. For this vision to be realized, we must continue investing in the foundations of quality data and digital systems. We hold AI tools to the same rigorous standards and accountability frameworks that guide other health investments, supporting countries in adopting tools that are tailored to their existing systems and maturity. While AI has incredible potential, it is also a completely new way of operating that needs to be introduced through secure, reasoned, ethical, evidence-based scaling. Countries with basic digital infrastructure – such as reliable power, health facility-level connectivity and digitized patient registers – can already implement simple AI tools. These include: triage chatbots, dashboard stock-out alerts or AI-driven text message reminders. As the digital systems of a country mature, more advanced applications can be deployed, such as predictive surveillance, automated image diagnostics and optimized healthcare administration and workforce productivity apps. Countries further along the maturity curve – with interoperable national health information exchanges, stable broadband and maintenance budgets – can consider advanced analytics, such as real-time outbreak forecasting or precision resource allocation models. AI must be adopted at a pace that can be sustained and scaled This staged approach ensures each country advances in its use of AI at a pace it can sustain and scale; the availability of a robust basic digital infrastructure is what enables Rwanda to use its Mpox skin image detection AI tool. Despite the obvious benefits of these investments, lower-income countries face high borrowing costs and constrained budgets. Concessional financing and grants from multilaterals can be supported by mobilizing pooled funds, securing preferential pricing on hardware and software and aligning institutional financing with national digital-health strategies and data standards. By underwriting shared infrastructure, such as solar-powered servers, regional analytics hubs or last-mile networks, these institutions absorb much of the initial risk, giving countries the runway they need to integrate AI into public systems, without shouldering the full financial burden up front. Of course, these must enable countries to take clear ownership and facilitate full sustainability, regardless of the initial funding source. To harness the power of AI for global health, institutional funders and governments can adopt these four key principles: 1. Assess readiness against maturity Evaluate every AI proposal based on where a given country sits on digital maturity and financial readiness curves. 2. Phase ambition Match the complexity of AI use cases to maturity levels. Start with simple tools, then extend to advanced AI as systems and budgets strengthen. 3. Mandate public–private co-investment The major AI innovations are driven by the private sector. Design funding so that governments, multilateral funding institutions and private partners share costs, expertise and risk and operate in a functional and sustainable digital marketplace. 4. Plan for ownership at each stage Define clear handover roadmaps that guide the transition from pilot to scaled platform, aligned with each phase of maturity. When AI adoption matches a country's evolving capacity and when multilateral funders convene all actors to share risk and build shared infrastructure, we unlock technology's true promise: smarter, more equitable health systems that can both end major diseases and endure. It's time to move beyond novelty towards solutions that work at scale and leave no one behind. This article is republished from The World Economic Forum under a Creative Commons license. Read the original article.
